AR and psychiatric disorder: 11 of the 110 female drug-adverse event pairs we identified with AR as a drug target had female-biased nervous system adverse events, and 11 of the 60 male drug-adverse event pairs were related to male-biased psychiatric disorders (Supplemental Fig. 13A & B).